The pharmaceutical sector in India is poised for significant expansion, with Hyderabad emerging as a pivotal hub for pharma exports. By 2026, the city is projected to solidify its standing as a leading center for pharmaceutical innovation and production. With a robust infrastructure, skilled workforce, and favorable government policies, Hyderabad is attracting both domestic and international investments.

The city’s existing facilities and research institutions are conducive for the development of generic drugs and novel therapeutics. As global demand for affordable medications rises, Indian pharma companies are focusing on quality and regulatory compliance, which enhances their competitiveness in international markets.

Moreover, initiatives like ‘Make in India’ are encouraging local manufacturers to ramp up production capacities. Collaborations with global firms and investments in biotechnology are further fueling growth. By 2026, Hyderabad is expected to significantly contribute to India’s vision of becoming a global leader in pharma exports, highlighting the city’s strategic importance in the global healthcare landscape.

For more details and the full reference, visit the source link below:

Read the complete article here: https://parliamentnews.co.uk/pharma-exports-india-2026-hyderabad